These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27934613)

  • 1. Complete blood flow obstruction due to a distally embolised Edwards SAPIEN valve prosthesis.
    Nijenhuis VJ; Swaans MJ; Ten Berg JM
    EuroIntervention; 2016 Dec; 12(11):e1436. PubMed ID: 27934613
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcatheter aortic valve replacement using the Edwards SAPIEN transcatheter heart valves.
    Huang PH; Eisenhauer AC
    Cardiol Clin; 2013 Aug; 31(3):337-50. PubMed ID: 23931098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of an iatrogenic membranous ventricular septal defect (IVSD) following Edwards SAPIEN 3 implantation by a valve-in-valve procedure.
    Rudolph TK; Scherner M; Kuhn E; Rudolph V; Mauri V; Rosenkranz S; Wahlers T; Baldus S; Mader N
    EuroIntervention; 2016 Apr; 11(13):1562. PubMed ID: 27107317
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
    Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrograde, transsubclavian implantation of a SAPIEN XT™ aortic valve prosthesis with the Edwards NovaFlex+™ system.
    Blumenstein J; Van Linden A; Kempfert J; Kim WK; Liebetrau C; Hamm C; Nef H; Walther T; Moellmann H
    Clin Res Cardiol; 2012 Sep; 101(9):773-5. PubMed ID: 22552833
    [No Abstract]   [Full Text] [Related]  

  • 6. Transapical implantation of an Edwards Sapien valve into a failed prosthetic mitral valve 3 years after a transapical aortic valve implantation.
    Neragi-Miandoab S; Mohr FW; Borger MA; Holzhey DM
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):e19-21. PubMed ID: 23111020
    [No Abstract]   [Full Text] [Related]  

  • 7. Transcatheter aortic valve-in-valve implantation of a CoreValve in a degenerated stenotic Sapien heart valve prosthesis.
    Hoffmann R; Möllmann H; Lotfi S
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E922-5. PubMed ID: 22707435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DynaCT-guided anatomical rotation of the SAPIEN XT valve during transapical aortic valve implantation: proof of concept.
    Blumenstein JM; Van Linden A; Moellmann H; Seeburger J; Rastan A; Kim WK; Mohr FW; Kempfert J; Walther T
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):409-13. PubMed ID: 23247690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter aortic implantation of the Edwards-SAPIEN bioprosthesis: insights on early benefit of TAVI on mitral regurgitation.
    Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Sieswerda G; Budde R; der Linden Mv; Samim M; Hillaert M; van Herwerden L; Doevendans PA; van Belle E
    Int J Cardiol; 2011 Oct; 152(1):124-6. PubMed ID: 21840071
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally invasive aortic valve replacement with sutureless valve is the appropriate treatment option for high-risk patients and the "real alternative" to transcatheter aortic valve implantation.
    Glauber M; Miceli A
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):610-613. PubMed ID: 26602264
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation.
    Kim WK; Praz F; Blumenstein J; Liebetrau C; Gaede L; Van Linden A; Hamm C; Walther T; Windecker S; Möllmann H
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):E38-E43. PubMed ID: 26945934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: The worldwide experience with the 29-mm Edwards SAPIEN XT™ transcatheter heart valve in patients with a large aortic annulus.
    Mack M
    Eur J Cardiothorac Surg; 2013 Feb; 43(2):377-8. PubMed ID: 22619317
    [No Abstract]   [Full Text] [Related]  

  • 14. Immediate and 6-month outcomes of transapical and transfemoral Edwards-Sapien prosthesis implantation in patients with aortic stenosis.
    Chodór P; Wilczek K; Przybylski R; Krasoń M; Głowacki J; Niklewski T; Podolecki T; Kalarus Z; Poloński L; Zembala M
    Kardiol Pol; 2010 Oct; 68(10):1124-31. PubMed ID: 20967708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worldwide experience with the 29-mm Edwards SAPIEN XT™ transcatheter heart valve in patients with large aortic annulus.
    Wendler O; Thielmann M; Schroefel H; Rastan A; Treede H; Wahlers T; Eichinger W; Walther T
    Eur J Cardiothorac Surg; 2013 Feb; 43(2):371-7. PubMed ID: 22522982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First valve-in-valve direct transaortic CoreValve implantation in an insufficient Sapien valve.
    van der Lienden BT; Swinkels BM; Heijmen RH; Mast EG; De Kroon TL; Ten Berg JM
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1049-50. PubMed ID: 21939949
    [No Abstract]   [Full Text] [Related]  

  • 17. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantation of a Sapien XT aortic bioprosthesis with the NovaFlex catheter through a subclavian access.
    Marcheix B; Grunenwald E; Carrie D; Dumonteil N
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):753-5. PubMed ID: 21955476
    [No Abstract]   [Full Text] [Related]  

  • 19. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
    Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Edwards SAPIEN Valve Degeneration After Transcatheter Aortic Valve Replacement.
    Harbaoui B; Courand PY; Schmitt Z; Farhat F; Dauphin R; Lantelme P
    JACC Cardiovasc Interv; 2016 Jan; 9(2):198-9. PubMed ID: 26711004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.